A carregar...
Efficacy and safety of oral sildenafil in children with Down syndrome and pulmonary hypertension
BACKGROUND: Despite the increased risk for pulmonary hypertension in children with Down syndrome, the response to treatment with targeted therapies for pulmonary hypertension in these patients is not well characterized. The Sildenafil in Treatment-naive children, Aged 1–17 years, with pulmonary arte...
Na minha lista:
| Publicado no: | BMC Cardiovasc Disord |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5496590/ https://ncbi.nlm.nih.gov/pubmed/28676038 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-017-0569-3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|